Exelixis (EXEL) Net Cash Flow (QoQ) (2010 - 2026)
Exelixis (EXEL) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Exelixis |
13.37 Bn |
12.59 Bn |
590.86 Mn |
| Date | Value |
|---|
| Apr 3, 2026 |
-341.40% |
| Jan 2, 2026 |
-49.88% |
| Oct 3, 2025 |
1,196.68% |
| Jul 4, 2025 |
42.54% |
| Apr 4, 2025 |
17.94% |
| Jan 3, 2025 |
-168.42% |
| Sep 27, 2024 |
198.01% |
| Jun 28, 2024 |
-1,679.84% |
| Mar 29, 2024 |
97.44% |
| Dec 29, 2023 |
-97.96% |
| Sep 29, 2023 |
12.86% |
| Jun 30, 2023 |
-296.94% |
| Mar 31, 2023 |
122.63% |
| Dec 30, 2022 |
-545.45% |
| Sep 30, 2022 |
139.24% |
| Jul 1, 2022 |
-235.71% |
| Apr 1, 2022 |
12.20% |
| Dec 31, 2021 |
10.50% |
| Oct 1, 2021 |
-50.42% |
| Jul 2, 2021 |
20.40% |
